ABSTRACT
One of the fascinating developments in recent years in the realm of renal cancer management has been the steady ascendancy of nephron-sparing surgery as a therapeutic arm. It is no longer considered a tentative surgical option, but a validated surgical principle designed to fetch long-term, cancer-free survival in organ-confined disease. Currently, its role in the management of advanced renal and metastatic disease is also being increasingly probed.
